Landscapes / Targets
CD73
12 drugs act on CD73, in 22 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs12
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
AstraZeneca · Public AZN |
Phase 3 | 8 Jan 2027Phase 3 trial completes | ||
| How it works | An antibody | ||||
| Next date | 8 Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2027Phase 2 trial completes | |||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Non-Small Cell Lung Cancer, Metastatic Pancreatic Ductal Adenocarcinoma | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 2/3 | 5 Aug 2028Phase 2/3 trial completes | |||
| How it works | An antibody | ||||
| Next date | 5 Aug 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | ||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor, Adult, Colorectal Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2027Phase 1/2 trial completes | |||
| Next date | Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2027Phase 1/2 trial completes | |||
| Next date | Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Non-small Cell Lung Cancer (NSCLC) | ||||
| Open drug page | |||||
Artificial immunoglobulin |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| How it works | An antibody | ||||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma | ||||
| Open drug page | |||||
— |
Huahai Pharmaceutical (Huaota) · Public 600521.SS |
Phase 1/2 | — | ||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 1 | May 2027Phase 1 trial completes | ||
| Next date | May 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignant Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Aug 2027Phase 1 trial completes | |||
| Next date | 30 Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 27 Dec 2027Phase 1 trial completes | |||
| Next date | 27 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumours | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 1 | — | ||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 12 of 12 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026